2019 is set to be a significant year for the development of drug delivery systems, particularly focused on cancer immunotherapy. Our latest whitepaper considers recent work in the field and details the extensive research N4 Pharma has been doing to develop Nuvec®, a unique non-viral adjuvant delivery system for vaccines and cancer treatments.